Frontlight ResearchEarly access
Trial site
Krakow
- 5running trials
- 9closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease4 trials
- Familial hypercholesterolaemia3 trials
- High blood pressure3 trials
- Chronic myeloid leukaemia2 trials
- Pulmonary arterial hypertension2 trials
- Stroke2 trials
- Asthma1 trial
- Gastric and oesophageal cancer1 trial
- Multiple sclerosis1 trial
- Peripheral artery disease1 trial
- Psoriatic arthritis1 trial
- Phase
- Phase 38 trials
- Phase 25 trials
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals14 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Terminated
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
Completed
Terminated
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
Completed
Completed
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026